triazolam has been researched along with Perceptual Disorders in 1 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
Perceptual Disorders: Cognitive disorders characterized by an impaired ability to perceive the nature of objects or concepts through use of the sense organs. These include spatial neglect syndromes, where an individual does not attend to visual, auditory, or sensory stimuli presented from one side of the body.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report two cases of severe withdrawal symptoms after abrupt discontinuation of a long-term normal-dose benzodiazepines (BZD) administration." | 1.27 | [Two cases of psychotic state following normal-dose benzodiazepine withdrawal]. ( Tani, Y; Terao, T, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Terao, T | 1 |
| Tani, Y | 1 |
1 other study available for triazolam and Perceptual Disorders
| Article | Year |
|---|---|
[Two cases of psychotic state following normal-dose benzodiazepine withdrawal].
Topics: Anti-Anxiety Agents; Cognition Disorders; Female; Humans; Male; Middle Aged; Nitrazepam; Perceptual | 1988 |